All stock reportsNEPHROPLUS evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-23T23:41:35.565831+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 9944680000.0
- net_income
- 768400000.0
- operating_cash_flow
- 2325790000.0
- free_cash_flow
- 1132170000.0
- total_assets
- 14708660000.0
- total_liabilities
- 3543730000.0
- total_equity
- 11164930000.0
- cash
- 1238890000.0
- total_debt
- Not supplied
- revenue_growth
- 0.32889152582234904
- earnings_growth
- 0.14522475259329926
- net_margin
- 0.07726744349742777
- roe
- 0.06882264376041766
- debt_to_equity
- Not supplied
- cash_conversion
- 3.026795939614784
- free_cash_flow_margin
- 0.11384680050036804
- trailing_pe
- Not supplied
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
Research only
1 opportunity assessments; compare evidence and conditions below.
Price Dislocation
Research only. Direction: LONG.
Flags large price dislocations for research without asserting unsupported fundamental quality
- No active, unexpired validation authority for this exact strategy and horizon.
- A source-backed entry, invalidation, exit and cost plan is not supplied.
- Eligible expression
- None selected
- Expression comparison
- No eligible instrument selected.
- Invalidation
- Continued price deterioration or adverse fundamental evidence
- Entry rule
- Not supplied
- Entry range (INR)
- Not supplied
- Exit / review rule
- Not supplied
- Planned exit
- Not supplied
- Plan valid until
- Not supplied
- Promotion reference
- Not supplied
- No reader capital or loss budget supplied
Decision provenance and limitations
- Decision ID
- decision-f86783136053431d783ab9c3d6a8ba5293b387a9bc2af610b973b2b154fb89cb
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 53e88dafaf3de448582a9e35df19d4cdafdb47bb3f0cad72ba70f16af2b3d235
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 03103ab5187d0f4ac165fd446016c7061642d5099f8c80da5418fd679d447c6c
- daily-price: f1397e02d94714e2d9339e3536a09afdea1bed024a2e35917f1531f41599fe45
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: VERIFIED.
- The cached closing price on 2026-10-01 was INR 648.95.
- The trailing 5-session price return was -8.53%.
- The trailing 20-session price return was -6.32%.
- The trailing 60-session price return was 1.47%.
- Average cached traded value over twenty sessions was INR 516,106,893.
- The closing price was -15.21% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-23T23:41:35.565831+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.32889152582234904.
- The cached financial metric net margin is 0.07726744349742777.
- The cached financial metric roe is 0.06882264376041766.
- The cached financial metric cash conversion is 3.026795939614784.
- The cached financial metric free cash flow margin is 0.11384680050036804.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.